Pearce Samantha sold 6,907 shares of Jazz Pharmaceuticals plc at $235.41 for −$1.63M on May 28, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
EVP, Chief Commercial Officer
EVP, Chief Commercial Officer
Filed Jun 1, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$1,625,976.87Shares × reported price
Shares traded
6,907Ordinary Shares
Price per share
$235.41Reported price. Read footnotes for ranges.
% of reported position traded
12.08%This security and ownership context
Holdings after
50,272Direct
Trade date
May 28, 2026Sell
Filed
Jun 1, 2026, 4:06 PM ET4-day reporting delay
Accession
0001805688-26-000008Code S · Transaction 388274
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 57,179 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 28, 2026Option exercise6,907$109.45$755,971.15Trade 388273
May 28, 2026Option exercise6,907$0.00$0Trade 388275
3 transaction rows in this filing. Joint filers share the same rows.

JAZZ price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
JAZZ · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −12%1w ago +2.9%1d ago +2.1%
Returns since7d −0.3%30d +2.1%90d +5.1%180d1y

Footnotes in full

F1: These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of March 2, 2020, 1/4th vested on the first anniversary of the vesting commencement date and the remainder vested in 36 equal monthly installments thereafter. The option was fully vested as of March 2, 2024.